Weekend Reading: Nervous Observers
Good Sunday morning. As always, here are some articles and papers worth reading. First, however, a look back at the week that just finished, and a look forward at the week ahead.
It was a mixed week for the major markets. The
Dow and the
S&P 500 went in opposite directions, with the Dow gaining 0.5% and the S&P 500 losing 0.5%. The ever-inconoclastic
Nasdaq lost 1.8% on the week.
Looking forward to next week, most observers remain nervous. Iran, oil prices, and the outlook for interest rates are all weighing on investors. That said, there is a sizable contingent of people treating this as a welcome pullback and an opportunity for putting money to work in the market.
Turning to the economic week ahead, on Thursday we will see the consumer price index for February. The Reuters consensus is for a 0.1% rise. On Tuesday we will receive retail sales data for February, and the consensus is for a 0.8 percent decline. Looking further out, the big event remains the FOMC meeting scheduled for March 27 and 28. It's now a slam-dunk certainty that rates will go up again.Next week is fairly quiet on the earnings front, with the fourth-quarter reporting season at last over. Reuters says that S&P 500 companies came in about 65% ahead of expectations, delivering the 14th consecutive quarter of year-over-year double-digit earnings growth. The main companies to watch this week will be the investment banks, with Goldman Sachs (GS), Bear Stearns (BSC), and Lehman Brothers (LEH) all set to report results for their first quarter, which ended Feb. 28. Finally, here are some articles and papers worth reading: Editor's note: To access some of these stories, registration or a subscription may be required. Please check the individual links for the site's policy.
- Remembering the sixth anniversary of the tech bubble's peak (Footnoted.org)
- Small pharma firms Cephalon (CEPH) , KOS (KOSP) and CollaGenex (CGPI) are delivering products, even if big pharma isn't (Fortune)
- A somewhat strained bullish argument for Yahoo over Google (Fortune)
- How bond honcho Bill Gross works (Fortune)
- Equity research conflicts still abound, says the author of a new book (Reuters)
- Are cuts in equity research constraining the IPO market? (Reuters)
- Tech equity follow-on issuance is up more than 50% year-over-year (IDD)
- Nasdaq makes a $2.4-billion takeover bid for the LSE (Bloomberg)
- The rapid rise of the anti-aging industry (BusinessWeek)
- Have Google's gaffes convinced investors that it's irresponsible? (BusinessWeek)
- Barron's is bullish on Boeing (BA), Avon (AVP) and ITG (ITG)
- Google's click fraud class-action settlement is called a cheap win (AdAge)
- Ken Fisher touts takeover candidates, including Korn/Ferry (ITG) (Forbes)
- Nortel retains its reputation as a serial restater (CFO)
- Abbott Labs and others are facing increasing pressure over "high" cancer drug prices (The New York Times)
- Citibank and others affects by largest debit card security breach ever (Computerworld)
- Worldwide growth in PC shipments expected to slow considerably this year (EETimes)
- An "excerpt" from Alan Greenspan's coming memoir (Slate)
- Research: The international debt, securities, and derivatives markets (Bank for International Settlements)
- Research: Adjustable-rate mortgage borrowers don't know how much their rates could change (The Federal Reserve Board)
- Research: Machine-learning techniques continue to challenge the efficient market hypthesis (Social Science Research Network)
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV